These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2007670)
1. Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. Knobler RM; Trautinger F; Radaszkiewicz T; Kokoschka EM; Micksche M J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):247-52. PubMed ID: 2007670 [TBL] [Abstract][Full Text] [Related]
2. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial. Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383 [TBL] [Abstract][Full Text] [Related]
3. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550 [TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. Olsen EA; Rosen ST; Vollmer RT; Variakojis D; Roenigk HH; Diab N; Zeffren J J Am Acad Dermatol; 1989 Mar; 20(3):395-407. PubMed ID: 2783939 [TBL] [Abstract][Full Text] [Related]
5. [Combination therapy with interferon alfa 2a and PUVA in cutaneous T-cell lymphoma]. Otte HG; Herges A; Stadler R Hautarzt; 1992 Nov; 43(11):695-9. PubMed ID: 1468931 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy. Stadler R; Otte HG Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306 [TBL] [Abstract][Full Text] [Related]
7. Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma. Straus DJ; Duvic M; Kuzel T; Horwitz S; Demierre MF; Myskowski P; Steckel S Cancer; 2007 May; 109(9):1799-803. PubMed ID: 17366595 [TBL] [Abstract][Full Text] [Related]
8. [Interferon-alpha in cutaneous T-cell lymphoma]. Knobler R Wien Med Wochenschr; 1993; 143(16-17):435-7. PubMed ID: 8273368 [TBL] [Abstract][Full Text] [Related]
9. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma. Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781 [TBL] [Abstract][Full Text] [Related]
10. The out-patient use of recombinant human interleukin-2 and interferon alfa-2b in advanced malignancies. Atzpodien J; Kirchner H Eur J Cancer; 1991; 27 Suppl 4():S88-91; discussion S92. PubMed ID: 1799491 [TBL] [Abstract][Full Text] [Related]
11. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a. Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188 [TBL] [Abstract][Full Text] [Related]
12. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma. Fimiani M; Rubegni P; De Aloe G; Andreassi L J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):502-3. PubMed ID: 10459134 [No Abstract] [Full Text] [Related]
13. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma. Zachariae H; Thestrup-Pedersen K J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637 [TBL] [Abstract][Full Text] [Related]
14. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078 [TBL] [Abstract][Full Text] [Related]
15. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva]. Römisch M; Meier W; Kimmig R; Hepp H Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064 [TBL] [Abstract][Full Text] [Related]
16. Treatment of cutaneous T cell lymphoma with low doses of interferon alpha-2b. Qiu B; Chen M Chin Med J (Engl); 1996 May; 109(5):404-6. PubMed ID: 9208501 [TBL] [Abstract][Full Text] [Related]
17. Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides. Altomare GF; Capella GL; Pigatto PD; Finzi AF Int J Dermatol; 1993 Feb; 32(2):138-41. PubMed ID: 8440560 [TBL] [Abstract][Full Text] [Related]
18. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954 [TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. Kuzel TM; Gilyon K; Springer E; Variakojis D; Kaul K; Bunn PA; Evans L; Roenigk HH; Rosen ST J Natl Cancer Inst; 1990 Feb; 82(3):203-7. PubMed ID: 2296050 [TBL] [Abstract][Full Text] [Related]
20. Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa. Vandersee S; Terhorst D; Humme D; Beyer M J Am Acad Dermatol; 2014 Apr; 70(4):709-715. PubMed ID: 24433874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]